| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 70 |
| 1 | ACETAMINOPHEN | 64 |
| 2 | PANTOPRAZOLE | 62 |
| 3 | VENETOCLAX | 53 |
| 4 | ALBUTEROL SULFATE | 52 |
| 5 | METFORMIN | 51 |
| 6 | METFORMIN ER 500 MG | 51 |
| 7 | METFORMIN ER 750 MG | 51 |
| 8 | PREDNISONE | 51 |
| 9 | ASPIRIN | 50 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ARGINASE | 1 | 1.0000 |
| 1 | MECLOFENAMATE SODIUM | 1 | 0.0182 |
| 2 | TRASTUZUMAB-DKST | 2 | 0.0073 |
| 3 | THIOTHIXENE | 1 | 0.0046 |
| 4 | HYDROCHLORIC ACID | 1 | 0.0045 |
| 5 | ILOPROST | 4 | 0.0043 |
| 6 | OLUTASIDENIB | 1 | 0.0035 |
| 7 | TEBENTAFUSP | 2 | 0.0033 |
| 8 | SUGAMMADEX | 9 | 0.0033 |
| 9 | CILTACABTAGENE AUTOLEUCEL | 21 | 0.0032 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 115 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 109 |
| 2 | Benzodiazepine [EPC] | 82 |
| 3 | Kinase Inhibitor [EPC] | 61 |
| 4 | Endothelin Receptor Antagonist [EPC] | 55 |
| 5 | BCL-2 Inhibitor [EPC] | 53 |
| 6 | Factor Xa Inhibitor [EPC] | 53 |
| 7 | Atypical Antipsychotic [EPC] | 51 |
| 8 | Loop Diuretic [EPC] | 51 |
| 9 | Opioid Agonist [EPC] | 51 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 9 | 0.0131 |
| 1 | Prostacycline [EPC] | 4 | 0.0043 |
| 2 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 2 | 0.0033 |
| 3 | Complement 5a Receptor Antagonist [EPC] | 13 | 0.0019 |
| 4 | Endoglycosidase [EPC] | 3 | 0.0016 |
| 5 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 2 | 0.0016 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 3 | 0.0014 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 8 | 0.0014 |
| 8 | Provitamin D2 Compound [EPC] | 37 | 0.0012 |
| 9 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 21 | 0.0012 |